ATE493649T1 - Verfahren zur diagnose von polyzystischer nierenkrankheit - Google Patents

Verfahren zur diagnose von polyzystischer nierenkrankheit

Info

Publication number
ATE493649T1
ATE493649T1 AT07700227T AT07700227T ATE493649T1 AT E493649 T1 ATE493649 T1 AT E493649T1 AT 07700227 T AT07700227 T AT 07700227T AT 07700227 T AT07700227 T AT 07700227T AT E493649 T1 ATE493649 T1 AT E493649T1
Authority
AT
Austria
Prior art keywords
kidney disease
polycystic kidney
diagnosing
diagnosing polycystic
pkd
Prior art date
Application number
AT07700227T
Other languages
English (en)
Inventor
Gerd Walz
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Application granted granted Critical
Publication of ATE493649T1 publication Critical patent/ATE493649T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Die Bonding (AREA)
  • Adhesive Tapes (AREA)
  • External Artificial Organs (AREA)
AT07700227T 2006-01-17 2007-01-17 Verfahren zur diagnose von polyzystischer nierenkrankheit ATE493649T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06000963A EP1808694A1 (de) 2006-01-17 2006-01-17 Verfahren zur Diagnose von polyzystischer Nierenerkrankung
PCT/EP2007/000384 WO2007082733A1 (en) 2006-01-17 2007-01-17 Method for diagnosing polycystic kidney disease

Publications (1)

Publication Number Publication Date
ATE493649T1 true ATE493649T1 (de) 2011-01-15

Family

ID=35945115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07700227T ATE493649T1 (de) 2006-01-17 2007-01-17 Verfahren zur diagnose von polyzystischer nierenkrankheit

Country Status (8)

Country Link
US (1) US20110229895A1 (de)
EP (3) EP1808694A1 (de)
AT (1) ATE493649T1 (de)
DE (1) DE602007011566D1 (de)
DK (2) DK1974210T3 (de)
ES (2) ES2356481T3 (de)
PL (2) PL1974210T3 (de)
WO (1) WO2007082733A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101370826A (zh) * 2006-02-09 2009-02-18 诺瓦提斯公司 抗分泌型卷曲相关蛋白-4(sfrp-4)的抗体
EP3358354B1 (de) 2008-01-18 2020-07-15 President and Fellows of Harvard College Verfahren zur detektion von anzeichen einer krankheit oder eines leidens in körperflüssigkeiten
WO2009132815A1 (en) 2008-04-30 2009-11-05 Roche Diagnostics Gmbh Use of sfrp-3 in the assessment of heart failure
EP2394171A2 (de) * 2008-12-17 2011-12-14 mosaiques diagnostics and therapeutics AG Autosomal dominante polyzystische nierenerkrankung (adpkd)
NZ624614A (en) * 2009-11-07 2015-10-30 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102713632B (zh) * 2009-12-23 2015-10-07 希尔氏宠物营养品公司 用于诊断和治疗犬肾脏病症的组合物和方法
AU2011281007A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting kidney-associated diseases or conditions
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
CA2806293A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
EP2678687B1 (de) * 2011-02-24 2015-09-02 Hill's Pet Nutrition, Inc. Zusammensetzungen und verfahren zur diagnostizierung und behandlung von nierenerkrankungen bei katzen
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
EP4202441A3 (de) 2013-03-09 2023-07-26 Immunis.AI, Inc. Genexpressionsprofil in makrophagen zur diagnose von krebs
WO2014197729A1 (en) 2013-06-05 2014-12-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
RU2017106891A (ru) 2014-08-04 2018-09-06 Джензим Корпорейшн Биомаркеры поликистозной болезни почек и пути их применения
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
US10456404B2 (en) 2015-03-13 2019-10-29 Indiana University Research And Technology Corporation Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
US10531837B1 (en) 2015-09-25 2020-01-14 Cerner Innovation, Inc. Predicting chronic kidney disease progression
JP6895963B2 (ja) 2015-11-18 2021-06-30 ジェンザイム・コーポレーション 多発性嚢胞腎のバイオマーカーおよびその使用
CN117337394A (zh) * 2021-05-17 2024-01-02 豪夫迈·罗氏有限公司 sFRP4作为血液生物标志物用于子宫腺肌病的非侵入性诊断
CN115060898B (zh) * 2021-07-01 2025-08-12 浙江大学 一种检测抗原肌球蛋白1-IgG抗体的试剂盒
EP4667628A1 (de) * 2024-06-19 2025-12-24 Albert-Ludwigs-Universität Freiburg Körperschaft des öffentlichen Rechts Synthetische letalität zur behandlung von autosomal dominanter polyzystischer nierenerkrankung (adpkd)
WO2025261741A1 (en) * 2024-06-19 2025-12-26 Albert-Ludwigs-Universitaet Freiburg Koerperschaft Des Oeffentlichen Rechts Synthetic lethality to treat autosomal dominant polycystic kidney disease (adpkd)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0879885A1 (de) * 1997-05-23 1998-11-25 Smithkline Beecham Corporation GEN für ein sekretiertes-Maus-sFRP-1-Protein ähnliches Protein
US6638726B1 (en) * 2000-01-06 2003-10-28 Mount Sinai School Of Medicine Of New York University Screening methods for compounds useful in the treatment of polycystic kidney disease
AU2001280680A1 (en) * 2000-07-19 2002-01-30 Genzyme Corporation Phosphatonin-related gene and methods of use thereof
US20030143610A1 (en) * 2002-01-08 2003-07-31 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
AU2003259285A1 (en) * 2002-07-29 2004-02-16 Hmgene, Inc. Methods of identifying adipocyte specific genes, the genes identified, and their uses
WO2004076639A2 (en) * 2003-02-26 2004-09-10 Wyeth Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
BRPI0510367A (pt) * 2004-04-29 2007-11-06 Genzyme Corp métodos e composições para o tratamento de doenças policìsticas

Also Published As

Publication number Publication date
PL1974210T3 (pl) 2011-05-31
PL2341344T3 (pl) 2014-09-30
EP2341344B1 (de) 2014-04-30
EP1974210B1 (de) 2010-12-29
DK2341344T3 (da) 2014-06-30
ES2356481T3 (es) 2011-04-08
EP1974210A1 (de) 2008-10-01
DE602007011566D1 (en) 2011-02-10
DK1974210T3 (da) 2011-02-21
ES2475540T3 (es) 2014-07-11
US20110229895A1 (en) 2011-09-22
EP1808694A1 (de) 2007-07-18
EP2341344A1 (de) 2011-07-06
WO2007082733A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
PL1974210T3 (pl) Sposób diagnozowania wielotorbielowatości nerek
DE602005024639D1 (de) Verfahren und Gerät zur Diagnose des Ermüdungsversagens von Turboladern
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
DE112006000054A5 (de) Verfahren zur Diagnose eines Abgasnachbehandlungssystems
ATE511656T1 (de) Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
NO20070949L (no) Transkriptomdiagnostikk i spytt
EP2215257A4 (de) Verfahren zur diagnose von tumorerkrankungen
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
WO2004112589A3 (en) Method for the detection of gene transcripts in blood and uses thereof
ATE528410T1 (de) Verfahren und zusammensetzungen zur diagnose von altersbedingter maculadegeneration
ATE535805T1 (de) Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
ATE533061T1 (de) Verfahren zur diagnose bakterieller infektionen
DE602004024539D1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
WO2007134028A3 (en) Biomarkers for depression and methods using the same
WO2012178188A3 (en) Molecular diagnostic panel of eosinophilic gastrointestinal disorders
DE602008000683D1 (de) Immunassay-Verfahren, Reagenzienkit zur Erkennung einer Alkali-Phosphatase und Reagenzienkit für das Immunassay-Verfahren
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
ATE488237T1 (de) Verfahren zur behandlung von abnormalem zellwachstum
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
ATE479100T1 (de) Verfahren zur diagnose von lawsonia intracellularis
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
ATE478335T1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
WO2011018710A3 (en) Biological components within the cerebrospinal fluid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1974210

Country of ref document: EP